“Drugs in the COVID-19 Pandemic: Analysis of the Commercialization of Azithromycin, Hydroxychloroquine, Ivermectin and Nitazoxanide in Brazil”. Research, Society and Development, vol. 11, no. 6, Apr. 2022, p. e16711628726, https://doi.org/10.33448/rsd-v11i6.28726.